Crestone

About:

Crestone is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism.

Website: https://www.crestonepharma.com/

Top Investors: National Institute of Allergy and Infectious Diseases, Cystic Fibrosis Foundation

Description:

Crestone is a clinical-stage biopharmaceutical business that is developing novel medication candidates. The following are in the company's research pipeline: C. Treatments for C. diff, antibiotic-resistant Gram-positive infections, and tuberculosis.

Total Funding Amount:

$18.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2009-01-01

Founders:

John Rohloff, Nebojsa Janjic, Thale Jarvis, Urs Ochsner

Number of Employees:

11-50

Last Funding Date:

2020-07-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai